Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)


Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!


Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.


I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC (http://www.videolan.org) to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (http://www.videolan.org).


Affichage des articles dont le libellé est NGS. Afficher tous les articles
Affichage des articles dont le libellé est NGS. Afficher tous les articles

"Edico Genome Aims at Data Processing Bottleneck in Whole Genome Sequencing"

"By mounting Edico’s proprietary Dragen processor on a standard computer expansion bus (similar to a graphics processing card) that is dedicated for genomics processing, van Rooyen says Edico’s technology could be installed in any next-generation sequencing machine—and would reduce the time needed to map a genome from 20 hours to 20 minutes.  (...) Van Rooyen says the underlying innovation of Edico’s technology is in the way the company implemented the genome-mapping algorithm, incorporating data compression techniques into a Field Programmable Gate Array (FPGA), a processor that is configured for specialized use after it is manufactured. (...) The company already is moving its design to a standard ASIC (Application Specific Integrated Circuit) processor, which typically can be mass-produced at low cost. (...) Van Rooyen’s commercialization plan calls for mounting the Dragen processor on cards that have been customized to work with specific genome sequencing machines, such as Illumina’s HiSeq X Ten. (...) By using Edico’s technology, van Rooyen says a facility using Illumina’s HiSeq X Ten machines to sequence 150 human genomes every three days would be able to save $6 million over a four-year period. (...) That would make it easier for hospitals and other healthcare providers to use genome sequencing to better diagnose heart disease, inflammatory disease, prenatal disease, and other conditions."

https://twitter.com/EdicoGenome
"With the arrival of next-generation gene sequencing machines like the Illumina (NASDAQ: ILMN) HiSeq X Ten, medicine has been moving to develop new ways of using genomic data to treat patients. Last month, for example, J. Craig Venter unveiled plans to sequence the entire genome of every patient entering the UC San Diego Moores Cancer Center as an initial goal for his latest startup, Human Longevity Inc.
At the same time, though, it’s becoming clear that generating genomic data for thousands of cancer patients involves working with very large numbers—and that means a wave of new opportunities for innovation are emerging as genomics and Big Data come together. One startup moving to catch this wave is Edico Genome, a San Diego startup founded last year to fix a bottleneck in the way the data being generated by the HiSeq X Ten and other next-generation sequencing machines is processed.
Edico has developed a specialized computer processor for ordering the readout of nucleotides—A, C, T, or G—from short segments of DNA generated by next-generation sequencing technology so they align with a reference genome. It’s a process that genomics specialists refer to as 'mapping.'
It is a Big Data problem. The human genome consists of roughly 3.2 billion nucleotide base pairs (made of that four-letter alphabet of DNA) that encode between 20,000 and 25,000 genes."

Clinical Interpretation and Implications of Whole-Genome Sequencing